[1]Synthesis,2014,vol.46,p.2175-2178
[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.5392-5397
[3]Patent:WO2004/69832,2004,A2.Locationinpatent:Page138
[4]JournalofMedicinalChemistry,1996,vol.39,p.2844-2851
123792-59-6
84531-36-2
84531-35-1
1443981-04-1
124-12-9 | OCTANENITRILE | AA000LAU | MFCD00001983
1242336-69-1 | 6-Bromo-5-fluoro-1H-benzo[d][1,2,3]triazole | AA000LNH | MFCD16660325
124499-21-4 | tert-Butyl 2-[4-(cyanomethyl)phenoxy]acetate | AA000M1A | MFCD22375028
1245816-10-7 | 5-Methyl-1H-indazol-4-yl boronic acid | AA000MCG | MFCD10001490
1247349-99-0 | 3-Bromo-4-isobutoxyaniline | AA000MM1 | MFCD13193213
1250756-65-0 | 6-oxaspiro[2.5]octan-1-amine | AA000N0V | MFCD16744511
125256-00-0 | Fatostatin | AA000NB8 | MFCD02376000
125455-62-1 | Sodium (2R,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexyl sulfate | AA000NN8 | MFCD00078771
125630-28-6 | 2-Pyrrolidinone, 1-methyl-3-(3-pyridinylcarbonyl)- | AA000NWN | MFCD00454717
1256355-55-1 | 3-(2-Methoxy-2-oxoethoxy)phenylboronic acid | AA000O1C | MFCD11973991